Cargando…
Mid-Regional Proadrenomedullin and Mid-Regional Proatrial Natriuretic Peptide Clearance Predicts Poor Outcomes Better Than Single Baseline Measurements in Critically Ill Patients With Pneumonia: A Retrospective Cohort Study
Background We assessed the ability of baseline and serial measurements of mid-regional proadrenomedullin (MR-proADM) and mid-regional proatrial natriuretic peptide (MR-proANP) to predict 28-day mortality in critically ill patients with pneumonia compared with Acute Physiological and Chronic Health E...
Autores principales: | Van Oers, Jos, Krabbe, Johannes, Kemna, Evelien, Kluiters, Yvette, Vos, Piet, De Lange, Dylan, Girbes, Armand, Beishuizen, Albertus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237920/ https://www.ncbi.nlm.nih.gov/pubmed/34221750 http://dx.doi.org/10.7759/cureus.15285 |
Ejemplares similares
-
Mid-regional proadrenomedullin, C-terminal proendothelin-1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity
por: van Oers, Jos A. H., et al.
Publicado: (2022) -
Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study
por: van Oers, Jos A.H., et al.
Publicado: (2021) -
A Pilot Study on the Diagnostic Accuracy of
Proadrenomedullin and Proatrial Natriuretic
Peptide in Lower Respiratory Tract Infections
por: Ruiz-González, Agustín, et al.
Publicado: (2014) -
Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021) -
Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)